Amplia Therapeutics announced the appointment of Dr. John Lambert as Chief Executive Officer. Long serving former CEO, Mr. Simon Wilkinson, will remain on the company's Board as a non-executive director. Based in Melbourne, Dr. Lambert has worked in drug discovery and development for over 20 years. His previous roles have included senior management positions at Biota Holdings Limited and Medicines Development for Global Health. His experience spans the full drug development lifecycle from early discovery, intellectual property protection, licensing, product development, and regulatory approval. John has been Amplia's Operations Manager since August 2018 and has been directing all aspects of the Company's clinical enabling work since that time.